Contact, publication, and social network information about Harvard faculty and fellows. Harvard Catalyst Profiles
Keywords
Last Name
Institution

profileD. Bradley Welling, M.D., Ph.D.

TitleWalter Augustus Lecompte Professor of Otology and Laryngology
InstitutionMassachusetts Eye and Ear Infirmary
DepartmentOtolaryngology
AddressMassachusetts Eye & Ear Infrm
ENT Education
243 Charles St
Boston MA 02114
Phone617/573-3654
Fax617
vCardDownload vCard (login for email)
Other Positions
TitleHead of the Department of Otolaryngology
InstitutionMassachusetts Eye and Ear Infirmary
DepartmentOtolaryngology


Collapse Bibliographic 
Collapse selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Welling DB, Stewart MG. A new open access journal. Laryngoscope. 2015 Sep; 125(9):2001. PMID: 26297169.
    View in: PubMed
  2. Welling DB. Classics from the laryngoscope. Laryngoscope. 2015 May; 125(5):1031-2. PMID: 25917653.
    View in: PubMed
  3. Moberly AC, Tweel BC, Welling DB. Wound breakdown after middle cranial fossa craniotomy: an unusual complication after rhytidectomy. Laryngoscope. 2014 Feb; 124(2):554-7. PMID: 24150991.
    View in: PubMed
  4. Welling DB, Stewart MG. Minimal reporting standard for reporting hearing outcomes. Laryngoscope. 2013 Feb; 123(2):303. PMID: 23254680.
    View in: PubMed
  5. Cipolla MJ, Iyer P, Dome C, Welling DB, Bush ML. Modification and comparison of minimally invasive cochleostomy techniques: A pilot study. Laryngoscope. 2012 May; 122(5):1142-7. PMID: 22447373.
    View in: PubMed
  6. Bush ML, Burns SS, Oblinger J, Davletova S, Chang LS, Welling DB, Jacob A. Treatment of vestibular schwannoma cells with ErbB inhibitors. Otol Neurotol. 2012 Feb; 33(2):244-57. PMID: 22222570; PMCID: PMC3522123.
  7. Wiet GJ, Stredney D, Kerwin T, Hittle B, Fernandez SA, Abdel-Rasoul M, Welling DB. Virtual temporal bone dissection system: OSU virtual temporal bone system: development and testing. Laryngoscope. 2012 Mar; 122 Suppl 1:S1-12. PMID: 22294268; PMCID: PMC3530401.
  8. Blakeley JO, Evans DG, Adler J, Brackmann D, Chen R, Ferner RE, Hanemann CO, Harris G, Huson SM, Jacob A, Kalamarides M, Karajannis MA, Korf BR, Mautner VF, McClatchey AI, Miao H, Plotkin SR, Slattery W, Stemmer-Rachamimov AO, Welling DB, Wen PY, Widemann B, Hunter-Schaedle K, Giovannini M. Consensus recommendations for current treatments and accelerating clinical trials for patients with neurofibromatosis type 2. Am J Med Genet A. 2012 Jan; 158A(1):24-41. PMID: 22140088; PMCID: PMC3319201.
  9. Jacob A, Oblinger J, Bush ML, Brendel V, Santarelli G, Chaudhury AR, Kulp S, La Perle KM, Chen CS, Chang LS, Welling DB. Preclinical validation of AR42, a novel histone deacetylase inhibitor, as treatment for vestibular schwannomas. Laryngoscope. 2012 Jan; 122(1):174-89. PMID: 22109824; PMCID: PMC3384504.
  10. Bush ML, Oblinger J, Brendel V, Santarelli G, Huang J, Akhmametyeva EM, Burns SS, Wheeler J, Davis J, Yates CW, Chaudhury AR, Kulp S, Chen CS, Chang LS, Welling DB, Jacob A. AR42, a novel histone deacetylase inhibitor, as a potential therapy for vestibular schwannomas and meningiomas. Neuro Oncol. 2011 Sep; 13(9):983-99. PMID: 21778190; PMCID: PMC3158011.
  11. Hurtuk A, Dome C, Holloman CH, Wolfe K, Welling DB, Dodson EE, Jacob A. Melatonin: can it stop the ringing? Ann Otol Rhinol Laryngol. 2011 Jul; 120(7):433-40. PMID: 21859051.
    View in: PubMed
  12. Wan D, Wiet GJ, Welling DB, Kerwin T, Stredney D. Creating a cross-institutional grading scale for temporal bone dissection. Laryngoscope. 2010 Jul; 120(7):1422-7. PMID: 20564671; PMCID: PMC3413455.
  13. Evans DG, Kalamarides M, Hunter-Schaedle K, Blakeley J, Allen J, Babovic-Vuskanovic D, Belzberg A, Bollag G, Chen R, DiTomaso E, Golfinos J, Harris G, Jacob A, Kalpana G, Karajannis M, Korf B, Kurzrock R, Law M, McClatchey A, Packer R, Roehm P, Rubenstein A, Slattery W, Tonsgard JH, Welling DB, Widemann B, Yohay K, Giovannini M. Consensus recommendations to accelerate clinical trials for neurofibromatosis type 2. Clin Cancer Res. 2009 Aug 15; 15(16):5032-5039. PMID: 19671848; PMCID: PMC4513640.
  14. Plotkin SR, Halpin C, Blakeley JO, Slattery WH, Welling DB, Chang SM, Loeffler JS, Harris GJ, Sorensen AG, McKenna MJ, Barker FG. Suggested response criteria for phase II antitumor drug studies for neurofibromatosis type 2 related vestibular schwannoma. J Neurooncol. 2009 May; 93(1):61-77. PMID: 19430883; PMCID: PMC4036446.
  15. Chang LS, Welling DB. Molecular biology of vestibular schwannomas. Methods Mol Biol. 2009; 493:163-77. PMID: 18839347.
    View in: PubMed
  16. Jacob A, Robinson LL, Bortman JS, Yu L, Dodson EE, Welling DB. Nerve of origin, tumor size, hearing preservation, and facial nerve outcomes in 359 vestibular schwannoma resections at a tertiary care academic center. Laryngoscope. 2007 Dec; 117(12):2087-92. PMID: 17921903.
    View in: PubMed
  17. Welling DB, Packer MD, Chang LS. Molecular studies of vestibular schwannomas: a review. Curr Opin Otolaryngol Head Neck Surg. 2007 Oct; 15(5):341-6. PMID: 17823551.
    View in: PubMed
  18. Neff BA, Wiet RM, Lasak JM, Cohen NL, Pillsbury HC, Ramsden RT, Welling DB. Cochlear implantation in the neurofibromatosis type 2 patient: long-term follow-up. Laryngoscope. 2007 Jun; 117(6):1069-72. PMID: 17545869.
    View in: PubMed
  19. Chang LS, Jacob A, Abraham J, Lorenz M, Rock J, Akhmametyeva EM, Mihai G, Schmalbrock P, Chaudhury AR, Lopez R, Yamate J, John MR, Wickert H, Neff BA, Dodson E, Welling DB. Growth of benign and malignant schwannoma xenografts in severe combined immunodeficiency mice. Laryngoscope. 2006 Nov; 116(11):2018-26. PMID: 17075413.
    View in: PubMed
  20. Neff BA, Oberstien E, Lorenz M, Chaudhury AR, Welling DB, Chang LS. Cyclin D(1) and D(3) expression in vestibular schwannomas. Laryngoscope. 2006 Mar; 116(3):423-6. PMID: 16540902.
    View in: PubMed
  21. Neff BA, Welling DB. Current concepts in the evaluation and treatment of neurofibromatosis type II. Otolaryngol Clin North Am. 2005 Aug; 38(4):671-84, ix. PMID: 16005725.
    View in: PubMed
  22. Jacob A, Kneile J, Welling DB. Angiofibrolipoma of the ear canal. Laryngoscope. 2005 Aug; 115(8):1461-2. PMID: 16094125.
    View in: PubMed
  23. Welling DB, Merrell JA, Merz M, Dodson EE. Predictive factors in pediatric stapedectomy. Laryngoscope. 2003 Sep; 113(9):1515-9. PMID: 12972926.
    View in: PubMed
  24. Lasak JM, Welling DB, Akhmametyeva EM, Salloum M, Chang LS. Retinoblastoma-cyclin-dependent kinase pathway deregulation in vestibular schwannomas. Laryngoscope. 2002 Sep; 112(9):1555-61. PMID: 12352662.
    View in: PubMed
  25. Welling DB, Lasak JM, Akhmametyeva E, Ghaheri B, Chang LS. cDNA microarray analysis of vestibular schwannomas. Otol Neurotol. 2002 Sep; 23(5):736-48. PMID: 12218628.
    View in: PubMed
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Welling's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description